Pediatrix Medical Group, Inc. $MD Shares Bought by LPL Financial LLC

Key Points

• LPL Financial LLC increased its stake in Pediatrix Medical Group by 55.5% during the first quarter, holding 144,318 shares valued at approximately $2.09 million.
• Research firms have raised their ratings and price targets for Pediatrix, with a consensus target price now at $16.75 and the stock holding an average rating of "Moderate Buy."
• Pediatrix Medical Group reported a net margin of 5.66% for the last quarter, with revenues of $468.84 million, slightly beating analyst forecasts but down 7.1% compared to the previous year.

LPL Financial LLC increased its stake in shares of Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) by 55.5% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 144,318 shares of the company's stock after buying an additional 51,490 shares during the quarter. LPL Financial LLC owned about 0.17% of Pediatrix Medical Group worth $2,091,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in MD. Oberweis Asset Management Inc. purchased a new position in shares of Pediatrix Medical Group during the fourth quarter worth about $6,122,000. Nomura Holdings Inc. purchased a new stake in shares of Pediatrix Medical Group during the 4th quarter worth approximately $3,882,000. Nuveen Asset Management LLC boosted its stake in shares of Pediatrix Medical Group by 110.8% during the 4th quarter. Nuveen Asset Management LLC now owns 485,587 shares of the company's stock worth $6,371,000 after acquiring an additional 255,273 shares in the last quarter. Raymond James Financial Inc. purchased a new stake in shares of Pediatrix Medical Group during the 4th quarter worth approximately $3,066,000. Finally, Teacher Retirement System of Texas lifted its stake in Pediatrix Medical Group by 92.3% in the 1st quarter. Teacher Retirement System of Texas now owns 371,756 shares of the company's stock valued at $5,387,000 after buying an additional 178,386 shares in the last quarter. Hedge funds and other institutional investors own 97.71% of the company's stock.

Wall Street Analyst Weigh In

A number of research firms recently issued reports on MD. Zacks Research raised Pediatrix Medical Group to a "strong-buy" rating in a research note on Monday, August 11th. Macquarie upped their price objective on Pediatrix Medical Group from $19.00 to $20.00 and gave the stock an "outperform" rating in a report on Thursday, May 8th. Finally, UBS Group upped their price target on shares of Pediatrix Medical Group from $16.00 to $16.50 and gave the stock a "neutral" rating in a research report on Thursday, August 14th. One research analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating and four have assigned a Hold rating to the stock. According to data from MarketBeat, Pediatrix Medical Group presently has an average rating of "Moderate Buy" and an average price target of $16.75.

Pediatrix Medical Group Stock Up 5.1%

NYSE:MD traded up $0.8230 on Friday, reaching $16.9730. The stock had a trading volume of 1,202,404 shares, compared to its average volume of 755,196. The stock has a market cap of $1.48 billion, a P/E ratio of 13.16 and a beta of 1.21. The company has a 50-day moving average of $13.70 and a 200 day moving average of $13.91. The company has a current ratio of 1.80, a quick ratio of 1.80 and a debt-to-equity ratio of 0.70. Pediatrix Medical Group, Inc. has a 12-month low of $10.06 and a 12-month high of $17.67.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last issued its earnings results on Tuesday, August 5th. The company reported $0.53 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.42 by $0.11. The business had revenue of $468.84 million for the quarter, compared to analyst estimates of $464.37 million. Pediatrix Medical Group had a net margin of 5.66% and a return on equity of 18.94%. The company's revenue for the quarter was down 7.1% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.34 EPS. On average, research analysts predict that Pediatrix Medical Group, Inc. will post 1.38 earnings per share for the current year.

Pediatrix Medical Group Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.